33 related articles for article (PubMed ID: 31234226)
1. Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia.
Zhao X; Wang P; Diedrich JD; Smart B; Reyes N; Yoshimura S; Zhang J; Yang W; Barnett K; Xu B; Li Z; Huang X; Yu J; Crews K; Yeoh AEJ; Konopleva M; Wei CL; Pui CH; Savic D; Yang JJ
Nat Commun; 2022 Sep; 13(1):5401. PubMed ID: 36104354
[TBL] [Abstract][Full Text] [Related]
2. The insertion/deletion polymorphism rs201494641 at
Cafaro C; Ali Z; Lamarca A; Di Bello DT; Lozano LD; Ekdahl L; Thodberg M; Pertesi M; De Lapuente Portilla AL; Nilsson B
Haematologica; 2024 May; ():. PubMed ID: 38721738
[TBL] [Abstract][Full Text] [Related]
3. EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia.
Hou Z; Ren Y; Zhang X; Huang D; Yan F; Sun W; Zhang W; Zhang Q; Fu X; Lang Z; Chu C; Zou B; Gao B; Jin B; Kang Z; Liu Q; Yan J
Cell Commun Signal; 2024 Apr; 22(1):211. PubMed ID: 38566191
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia.
Yasuda T; Sanada M; Tsuzuki S; Hayakawa F
Cancer Sci; 2023 Jan; 114(1):8-15. PubMed ID: 36106363
[TBL] [Abstract][Full Text] [Related]
5. ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia.
Dickerson KM; Qu C; Gao Q; Iacobucci I; Gu Z; Yoshihara H; Backhaus EA; Chang Y; Janke LJ; Xu B; Wu G; Papachristou EK; D'Santos CS; Roberts KG; Mullighan CG
Blood Cancer Discov; 2022 May; 3(3):240-263. PubMed ID: 35247902
[TBL] [Abstract][Full Text] [Related]
6. The Novel Regulatory Role of lncRNA-miRNA-mRNA Axis in Amyotrophic Lateral Sclerosis: An Integrated Bioinformatics Analysis.
Liu D; Zuo X; Zhang P; Zhao R; Lai D; Chen K; Han Y; Wan G; Zheng Y; Lu C; Gu X
Comput Math Methods Med; 2021; 2021():5526179. PubMed ID: 33953791
[TBL] [Abstract][Full Text] [Related]
7. ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
Zhu L; Bai W; Cheng Q; Fang J
Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
[TBL] [Abstract][Full Text] [Related]
8. Mixed Phenotype Acute Leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and Other Chromosome Abnormalities.
Yamamoto K; Kawamoto S; Mizutani Y; Yakushijin K; Yamashita T; Nakamachi Y; Kawano S; Hayashi Y; Matsuoka H; Minami H
Cytogenet Genome Res; 2016; 149(3):165-170. PubMed ID: 27607436
[TBL] [Abstract][Full Text] [Related]
9. ZNF384-fusion proteins have high affinity for the transcriptional coactivator EP300 and aberrant transcriptional activities.
Yamamoto H; Hayakawa F; Yasuda T; Odaira K; Minamikawa Y; Tange N; Hirano D; Kojima Y; Morishita T; Tsuzuki S; Naoe T; Kiyoi H
FEBS Lett; 2019 Aug; 593(16):2151-2161. PubMed ID: 31234226
[TBL] [Abstract][Full Text] [Related]
10. Detection of EP300-ZNF384 fusion in patients with acute lymphoblastic leukemia using RNA fusion gene panel sequencing.
Jing Y; Li YF; Wan H; Liu DH
Ann Hematol; 2020 Nov; 99(11):2611-2617. PubMed ID: 32980888
[TBL] [Abstract][Full Text] [Related]
11. Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.
McClure BJ; Heatley SL; Kok CH; Sadras T; An J; Hughes TP; Lock RB; Yeung D; Sutton R; White DL
Br J Cancer; 2018 Apr; 118(7):1000-1004. PubMed ID: 29531323
[TBL] [Abstract][Full Text] [Related]
12. Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.
Qian M; Zhang H; Kham SK; Liu S; Jiang C; Zhao X; Lu Y; Goodings C; Lin TN; Zhang R; Moriyama T; Yin Z; Li Z; Quah TC; Ariffin H; Tan AM; Shen S; Bhojwani D; Hu S; Chen S; Zheng H; Pui CH; Yeoh AE; Yang JJ
Genome Res; 2017 Feb; 27(2):185-195. PubMed ID: 27903646
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
